Shefali AGARWAL, MD
Before joining Onxeo, Dr. Shefali Agarwal was Chief Medical Officer at Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies […]
Before joining Onxeo, Dr. Shefali Agarwal was Chief Medical Officer at Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies […]
Julien Miara is a Principal at Invus. He joined in 2010 as an analyst in the Public Equity group, covering […]
Bryan Giraudo is both the Chief Operating Officer & Chief Financial Officer of Gossamer Bio, a U.S. listed biopharmaceutical company […]
Nicolas Trebouta is a Doctor of Medicine. Co-founder of Chevrillon and Associates in 2000, Nicolas Trebouta has lead several buyouts […]
Danièle Guyot-Caparros is a chartered accountant. Danièle Guyot-Caparros is graduated from the Ecole Supérieure de Commerce of Nancy in finance […]
Jacques Mallet, MD, served as SVP – Head of Portfolio Analytics/Corporate Strategy and Member of the Executive Leadership Team of […]
Robert L. Coleman, MD, is the Chief Scientific Officer of US Oncology Research, one of the U.S. largest networks dedicated […]